Wambeke David J.
SEC insider (Form 3/4/5 filer). CIK 0001971798. Chief Business Officer at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 28, 2026. Located in EDEN PRAIRIE, MN.
Companies Wambeke David J. has filed insider reports for
- NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC): Officer, Chief Business Officer
- DiaMedica Therapeutics Inc. (DMAC): Officer, Chief Business Officer
Wambeke David J.
CIK: 0001971798
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 28, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
AwardDirectOption to Purchase Common Stock
35K shares- - Aug 27, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
PurchaseDirect33.3K shares at avg. $2.01$67K - Mar 1, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
PurchaseDirect1M shares at avg. $0.67$670K - Mar 1, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
AwardDirectOption to Purchase Common Stock
500K shares- - Jun 1, 2025DMAC
DiaMedica Therapeutics Inc.
AwardDirectStock Option (right to buy)
250K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 28, 2026 |  NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Award Option to Purchase Common Stock | 35,000 | - | - | Direct |
| Aug 27, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Purchase | 33,333 | $2.01 | $66,999 | Direct |
| Mar 1, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Purchase | 1,000,000 | $0.67 | $670,400 | Direct |
| Mar 1, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Award Option to Purchase Common Stock | 500,000 | - | - | Direct |
| Jun 1, 2025 |  DMAC DiaMedica Therapeutics Inc. | Award Stock Option (right to buy) | 250,000 | - | - | Direct |
1-5 of 5 transactions